Articles

Search Articles

Advanced search
Help

Catalogue

Articles

Databases

X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (263) 263
Publication (19) 19
Newspaper Article (15) 15
Book Review (13) 13
Patent (8) 8
Book Chapter (5) 5
Book / eBook (4) 4
Magazine Article (4) 4
Trade Publication Article (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (152) 152
respiratory system (98) 98
index medicus (79) 79
adult (75) 75
female (70) 70
male (69) 69
transplantation (59) 59
middle aged (58) 58
lung transplantation (55) 55
cardiac & cardiovascular systems (51) 51
surgery (45) 45
treatment outcome (38) 38
pulmonary hypertension (33) 33
retrospective studies (28) 28
lung transplantation - adverse effects (27) 27
survival (25) 25
disease (23) 23
adolescent (22) 22
aged (22) 22
transplantation of organs, tissues, etc (22) 22
critical care medicine (20) 20
cystic fibrosis (20) 20
prognosis (20) 20
risk factors (20) 20
young adult (19) 19
abridged index medicus (18) 18
mortality (18) 18
transplants & implants (18) 18
care and treatment (17) 17
heart (17) 17
lungs (17) 17
bronchiolitis obliterans - etiology (16) 16
time factors (15) 15
analysis (14) 14
follow-up studies (14) 14
bronchiolitis obliterans syndrome (13) 13
forced expiratory volume (13) 13
recipients (13) 13
therapy (13) 13
cystic fibrosis - surgery (12) 12
immunology (12) 12
inflammation (12) 12
medicine, general & internal (12) 12
survival rate (12) 12
diagnosis (11) 11
hypertension, pulmonary (11) 11
hypertension, pulmonary - therapy (11) 11
lung transplantation - mortality (11) 11
outcomes (11) 11
risk-factors (11) 11
tissue donors (11) 11
bronchiolitis-obliterans-syndrome (10) 10
child (10) 10
cystic fibrosis - microbiology (10) 10
heart-lung transplantation (10) 10
hypertension, pulmonary - etiology (10) 10
hypertension, pulmonary - surgery (10) 10
patient selection (10) 10
prospective studies (10) 10
rejection (10) 10
research (10) 10
allografts (9) 9
cystic-fibrosis (9) 9
double-blind (9) 9
hypertension (9) 9
lung - pathology (9) 9
management (9) 9
quality of life (9) 9
survival analysis (9) 9
usage (9) 9
antihypertensive agents - therapeutic use (8) 8
arterial-hypertension (8) 8
asthma (8) 8
bronchoalveolar lavage (8) 8
drug therapy (8) 8
endarterectomy (8) 8
hypertension, pulmonary - diagnosis (8) 8
hypertension, pulmonary - drug therapy (8) 8
hypertension, pulmonary - mortality (8) 8
immunosuppressive agents - therapeutic use (8) 8
mutation (8) 8
patients (8) 8
pulmonary and respiratory medicine (8) 8
pulmonary/respiratory (8) 8
respiratory tract diseases (8) 8
anti-bacterial agents - therapeutic use (7) 7
cells, cultured (7) 7
drug therapy, combination (7) 7
experience (7) 7
health aspects (7) 7
heart transplantation (7) 7
hypertension, pulmonary - genetics (7) 7
infection (7) 7
infections (7) 7
lung - physiopathology (7) 7
lung transplantation - immunology (7) 7
lung transplantation - methods (7) 7
lung transplantation - physiology (7) 7
pulmonary arteries (7) 7
referral and consultation (7) 7
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Robarts - Stacks (2) 2
Gerstein Science - Stacks (1) 1
St. Michael's College (John M. Kelly) - 2nd Floor (1) 1
UTL at Downsview - May be requested (1) 1
UofT at Mississauga - Stacks (1) 1
UofT at Scarborough - Stacks (1) 1
Victoria University E.J. Pratt - Oversize (1) 1
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


1. Management of heart and lung transplant patients
by Corris, Paul A and Schofield, Peter M
1998, ISBN 9780727913654, x, 230
Heart | Transplantation | Lungs | Patients
Book
Details down arrow
2. Paul′s soapbox
by Corris, Paul
PVRI Review, ISSN 0974-6013, 01/2012, Volume 4, Issue 1, p. 62
Journal Article
Details down arrow
3. Full Text Identification of rare sequence variation underlying heritable pulmonary arterial hypertension
by Graf, Stefan and Haimel, Matthias and Bleda, Marta and Hadinnapola, Charaka and Southgate, Laura and Li, Wei and Hodgson, Joshua and Liu, Bin and Salmon, Richard M and Southwood, Mark and Machado, Rajiv D and Martin, Jennifer M and Treacy, Carmen M and Yates, Katherine and Daugherty, Louise C and Shamardina, Olga and Whitehorn, Deborah and Holden, Simon and Aled, Micheala and Bogaard, Harm J and Church, Colin and Coghlan, Gerry and Condliffe, Robin and Corris, Paul A and Danesino, Cesare and Eyries, Melanie and Gall, Henning and Ghio, Stefano and Ghofrani, Hossein-Ardeschir and Gibbs, J. Simon R and Girerd, Barbara and Houweling, Arjan C and Howard, Luke and Humbert, Marc and Kiely, David G and Kovacs, Gabor and Ross, Robert V. MacKenzie and Moledina, Shahin and Montani, David and Newnham, Michael and Olschewski, Anea and Olschewski, Horst and Peacock, Anew J and Pepke-Zaba, Joanna and Prokopenko, Inga and Rhodes, Christopher J and Scelsi, Laura and Seeger, Werner and Soubrier, Florent and Stein, Dan F and Suntharalingam, Jay and Swietlik, Emilia M and Toshner, Mark R and van Heel, David A and Noordegraaf, Anton Vonk and Waisfisz, Quinten and Wharton, John and Wort, Stephen J and Ouwehand, Willem H and Soranzo, Nicole and Lawrie, Allan and Upton, Paul D and Wilkins, Martin R and Trembath, Richard C and Morrell, Nicholas W
Nature Communications, ISSN 2041-1723, 04/2018, Volume 9, Issue 1, pp. 1416 - 16
Pulmonary arterial hypertension (PAH) is a rare disorder with a poor prognosis. Deleterious variation within components of the transforming growth factor-beta... 
a_open_article_in_open_journal | SOX17 | GENE | ANGIOGENESIS | CRYSTAL-STRUCTURE | MULTIDISCIPLINARY SCIENCES | BMP9 | ASSOCIATION | EXPRESSION | NONSENSE MUTATION | BETA-RECEPTOR | CAVEOLIN-1 | Prognosis | Humans | Male | Familial Primary Pulmonary Hypertension - diagnosis | SOXF Transcription Factors - metabolism | Aquaporin 1 - metabolism | Case-Control Studies | Familial Primary Pulmonary Hypertension - metabolism | Membrane Transport Proteins - genetics | Base Sequence | HEK293 Cells | Adult | Female | Growth Differentiation Factors - genetics | Membrane Transport Proteins - metabolism | Familial Primary Pulmonary Hypertension - pathology | Genetic Predisposition to Disease | Bone Morphogenetic Protein Receptors, Type II - genetics | Signal Transduction | Gene Expression Regulation | Adenosine Triphosphatases - metabolism | Models, Molecular | Familial Primary Pulmonary Hypertension - genetics | Bone Morphogenetic Protein Receptors, Type II - metabolism | Membrane Transport Proteins - chemistry | Whole Genome Sequencing | Aquaporin 1 - chemistry | Aquaporin 1 - genetics | Growth Differentiation Factors - metabolism | Transforming Growth Factor beta - genetics | Adenosine Triphosphatases - chemistry | Adenosine Triphosphatases - genetics | Mutation | SOXF Transcription Factors - genetics | Transforming Growth Factor beta - metabolism | SOXF Transcription Factors - chemistry | Growth Differentiation Factors - chemistry | Hypertension | Bone morphogenetic protein receptor type II | Secretion | Transforming growth factor | Genes | Genomes | Heritability | Aquaporin 1 | Gene sequencing
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
4. Full Text Updated Treatment Algorithm of Pulmonary Arterial Hypertension
by Galiè, Nazzareno, MD and Corris, Paul A., MD and Frost, Adaani, MD and Girgis, Reda E., MD and Granton, John, MD and Jing, Zhi Cheng, MD and Klepetko, Walter, MD and McGoon, Michael D., MD and McLaughlin, Vallerie V., MD and Preston, Ioana R., MD and Rubin, Lewis J., MD and Sandoval, Julio, MD and Seeger, Werner, MD and Keogh, Anne, MD
JACC (Journal of the American College of Cardiology), ISSN 0735-1097, 2013, Volume 62, Issue 25, pp. D60 - D72
The demands on a pulmonary arterial hypertension (PAH) treatment algorithm are multiple and in some ways conflicting. The treatment algorithm usually includes... 
Cardiovascular | Internal Medicine | endothelin receptor antagonists | phosphodiesterase type-5 inhibitors | prostanoids | guanylate cyclase stimulators | hypertension, pulmonary | pulmonary | lung transplantation | INHALED ILOPROST | SURROGATE END-POINTS | CARDIAC & CARDIOVASCULAR SYSTEMS | INTERNATIONAL-SOCIETY | COMBINATION THERAPY | AMBRISENTAN THERAPY | EISENMENGER-SYNDROME | CONTINUOUS INTRAVENOUS EPOPROSTENOL | HEART-LUNG TRANSPLANTATION | DOUBLE-BLIND | QUALITY-OF-LIFE | Medical colleges | Calcium channels | Algorithms | Pulmonary hypertension
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
5. Full Text The good the bad and the ugly
by Corris, Paul A and Sithamparanathan, Sasiharan and Thirugnanasothy, Logan
Thorax, ISSN 0040-6376, 09/2014, Volume 69, Issue 9, p. 870
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
6. Full Text The good the bad and the ugly
by Corris, Paul A and Sithamparanathan, Sasiharan and Thirugnanasothy, Logan
Thorax, ISSN 0040-6376, 09/2014, Volume 69, Issue 9, pp. 870 - 871
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
7. Full Text The good the bad and the ugly
by Paul A Corris and Sasiharan Sithamparanathan and Logan Thirugnanasothy
Thorax, ISSN 0040-6376, 09/2014, Volume 69, Issue 9, p. 870
  In idiopathic PH, there is clear evidence of benefit in combining parenteral epoprostenol with an oral phosphodiesterase inhibitor 5 and 7 of the 15 patients... 
Clinical trials | Editorials | Patients
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
8. Full Text The good the bad and the ugly
by Corris, Paul A and Sithamparanathan, Sasiharan and Thirugnanasothy, Logan
Thorax, ISSN 0040-6376, 2014, Volume 69, Issue 9, pp. 870 - 871
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
9. Full Text A consensus document for the selection of lung transplant candidates: 2014—An update from the Pulmonary Transplantation Council of the International Society for Heart and Lung Transplantation
by Weill, David, MD and Benden, Christian, MD and Corris, Paul A., MD and Dark, John H., FRCS and Davis, R. Duane, MD and Keshavjee, Shaf, MD and Lederer, David J., MD and Mulligan, Michael J., MD and Patterson, G. Alexander, MD and Singer, Lianne G., MD and Snell, Greg I., MD and Verleden, Geert M., MD, PhD and Zamora, Martin R., MD and Glanville, Allan R., MBBS, MD
Journal of Heart and Lung Transplantation, ISSN 1053-2498, 2015, Volume 34, Issue 1, pp. 1 - 15
The appropriate selection of lung transplant recipients is an important determinant of outcomes. This consensus document is an update of the recipient... 
Surgery | lung transplantation | interstitial lung disease | cystic fibrosis | pulmonary hypertension | emphysema | BURKHOLDERIA-CEPACIA COMPLEX | SURGERY | SINGLE-CENTER EXPERIENCE | CARDIAC & CARDIOVASCULAR SYSTEMS | FOCUS THEME AGE | LIVER-TRANSPLANTATION | SYSTEMIC-SCLEROSIS | TRANSPLANTATION | BRONCHIOLOALVEOLAR CARCINOMA | RESPIRATORY SYSTEM | CYSTIC-FIBROSIS PATIENTS | VOLUME REDUCTION SURGERY | EXTRACORPOREAL MEMBRANE-OXYGENATION | AIR-FLOW OBSTRUCTION | Referral and Consultation - organization & administration | Societies, Medical | Humans | Waiting Lists | Retrospective Studies | Heart-Lung Transplantation - methods | Consensus | Tissue Donors - supply & distribution | Patient Selection | Transplantation of organs, tissues, etc | Organ transplant recipients
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
10. An international ISHLT/ATS/ERS clinical practice guideline: Diagnosis and management of bronchiolitis obliterans syndrome
by Meyer, Keith C and Raghu, Ganesh and Verleden, Geert M and Corris, Paul A and Aurora, Paul and Wilson, Kevin C and Brozek, Jan and Glanville, Allan R and Egan, Jim J.J and Arcasoy, Selim and Aris, Robert M and Avery, Robin K and Belperio, John and Behr, Juergen and Bhorade, Sangeeta and Boehler, Annette and Chaparro, Cecilia and Christie, Jason D and Dupont, Lieven J and Estenne, Marc and Fisher, Andrew J and Garrity, Edward R and Hadjiliadis, Denis and Hertz, Marshall I and Husain, Shahid and Iversen, Martin and Keshavjee, Shaf and Lama, Vibha N and Levine, Deborah J and Levine, Stephanie M and Lee, James C and Massard, Gilbert and Mehta, Atul C and Nathan, Steven D and Orens, Jonathan B and Palmer, Scott M and Snell, Greg I and Stern, Marc and Studer, Sean M and Sweet, Stuart C and Tazelaar, Henry D and Whelan, Timothy P and Wilkes, David S and Williams, Trevor J and Zamora, Martin R and ISHLT ATS ERS BOS Task Force Comm and ISHLT/ATS/ERS BOS Task Force Committee
European Respiratory Journal, ISSN 0903-1936, 12/2014, Volume 44, Issue 6, pp. 1479 - 1503
Bronchiolitis obliterans syndrome (BUS) is a major complication of lung transplantation that is associated with poor survival. The International Society for... 
GASTROESOPHAGEAL-REFLUX DISEASE | RESPIRATORY SYSTEM | LAPAROSCOPIC NISSEN FUNDOPLICATION | LONG-TERM AZITHROMYCIN | CHRONIC ALLOGRAFT-REJECTION | PRIMARY GRAFT DYSFUNCTION | REGULATORY T-CELLS | THIN-SECTION CT | LUNG-TRANSPLANT RECIPIENTS | TOTAL LYMPHOID IRRADIATION | MINIMAL ACUTE REJECTION | Reoperation | Lung - pathology | Graft Rejection - prevention & control | Humans | Immunosuppressive Agents - therapeutic use | Risk Factors | Tomography, X-Ray Computed | Gastroesophageal Reflux - epidemiology | Lung - diagnostic imaging | Lung - physiopathology | Adrenal Cortex Hormones - therapeutic use | Bronchiolitis Obliterans - diagnosis | Forced Expiratory Volume | Anti-Bacterial Agents - therapeutic use | Cyclosporine - therapeutic use | Gastroesophageal Reflux - surgery | Tacrolimus - therapeutic use | Lung Transplantation | Graft Rejection - epidemiology | Azithromycin - therapeutic use | Biopsy | Disease Management | Bronchiolitis Obliterans - therapy
Journal Article
Details down arrow
11. Full Text A randomised controlled trial of azithromycin therapy in bronchiolitis obliterans syndrome (BOS) post lung transplantation
by Corris, Paul A and Ryan, Victoria A and Small, Therese and Lordan, James and Fisher, Andrew J and Meachery, Gerard and Johnson, Gail and Ward, Chris
Thorax, ISSN 0040-6376, 05/2015, Volume 70, Issue 5, pp. 442 - 450
Background We conducted a placebo-controlled trial of azithromycin therapy in bronchiolitis obliterans syndrome (BOS) post lung transplantation. Methods We... 
NEUTROPHILIA | RESPIRATORY SYSTEM | LONG-TERM AZITHROMYCIN | MAINTENANCE AZITHROMYCIN | ASTHMA | RISK | RECIPIENTS | CHRONIC REJECTION | BRONCHOALVEOLAR LAVAGE | Double-Blind Method | Bronchiolitis Obliterans - etiology | Humans | Middle Aged | Male | Treatment Outcome | Lung Transplantation - adverse effects | Syndrome | Bronchiolitis Obliterans - diagnosis | Forced Expiratory Volume | Anti-Bacterial Agents - therapeutic use | Azithromycin - therapeutic use | Adult | Female | Bronchiolitis Obliterans - drug therapy | Clinical trials | Usage | Care and treatment | Dosage and administration | Azithromycin | Bronchiolitis | Studies | Clinical medicine | Transplants & implants | Drug dosages | Mortality | Neutrophils | 1506 | Lung Transplantation
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
12. Full Text Changing demographics, epidemiology, and survival of incident pulmonary arterial hypertension: Results from the pulmonary hypertension registry of the United Kingdom and Ireland
by Ling, Yi and Johnson, Martin K and Kiely, David G and Condliffe, Robin and Elliot, Charlie A and Gibbs, J. Simon R and Howard, Luke S and Pepke-Zaba, Joanna and Sheares, Karen K. K and Corris, Paul A and Fisher, Andrew J and Lordan, James L and Gaine, Sean and Coghlan, J. Gerry and Wort, S. John and Gatzoulis, Michael A and Peacock, Andrew J
American Journal of Respiratory and Critical Care Medicine, ISSN 1073-449X, 10/2012, Volume 186, Issue 8, pp. 790 - 796
Rationale: Incident pulmonary arterial hypertension was underrepresented in most pulmonary hypertension registries and may have a different disease profile to... 
Aging | Epidemiology | Survival | Pulmonary hypertension | epidemiology | REVEAL REGISTRY | RISK PREDICTION | SWISS REGISTRY | RESPIRATORY SYSTEM | pulmonary hypertension | PERFORMANCE | survival | PREDICTION MODELS | aging | CRITICAL CARE MEDICINE | Hypertension, Pulmonary - mortality | Multivariate Analysis | Age Distribution | Prospective Studies | Survival Rate - trends | Comorbidity | Humans | Middle Aged | Risk Factors | Kaplan-Meier Estimate | Proportional Hazards Models | Hypertension, Pulmonary - physiopathology | Ireland - epidemiology | Male | Hypertension, Pulmonary - epidemiology | Incidence | Registries - statistics & numerical data | Adult | Female | Aged | United Kingdom - epidemiology
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
13. Full Text Connective Tissue Disease-associated Pulmonary Arterial Hypertension in the Modern Treatment Era
by Condliffe, Robin and Kiely, David G and Peacock, Andrew J and Corris, Paul A and Gibbs, J. Simon R and Vrapi, Florenc and Das, Clare and Elliot, Charlie A and Johnson, Martin and DeSoyza, Julia and Torpy, Chantal and Goldsmith, Kim and Hodgkins, Denise and Hughes, Rodney J and Pepke-Zaba, Joanna and Coghlan, J. Gerry
American Journal of Respiratory and Critical Care Medicine, ISSN 1073-449X, 01/2009, Volume 179, Issue 2, pp. 151 - 157
Rationale Pulmonary arterial hypertension in association with connective tissue disease (CTD-PAH) has historically had a poor prognosis, with a 1-year survival... 
Connective tissue disease | Systemic lupus erythematosus | Survival | Systemic sclerosis | Pulmonary hypertension | CONTROLLED-TRIAL | SYSTEMIC-LUPUS-ERYTHEMATOSUS | pulmonary hypertension | survival | SCLEROSIS | SCLERODERMA SPECTRUM | connective tissue disease | systemic lupus erythematosus | systemic sclerosis | RESPIRATORY SYSTEM | BOSENTAN TREATMENT | REGISTRY | CRITICAL CARE MEDICINE | Hypertension, Pulmonary - mortality | Hypertension, Pulmonary - diagnosis | Lupus Erythematosus, Systemic - complications | Humans | Middle Aged | Risk Factors | Connective Tissue Diseases - diagnosis | Male | Survival Rate | Exercise Therapy | Hypertension, Pulmonary - therapy | Scleroderma, Systemic - complications | Female | Aged | Retrospective Studies | Hypertension, Pulmonary - etiology | United Kingdom - epidemiology | Connective Tissue Diseases - complications | Cohort Studies
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
14. Full Text Upfront combination therapy: does the AMBITION study herald a new era in the treatment of pulmonary arterial hypertension?
by Nathan, Steven D and Corris, Paul A
Thorax, ISSN 0040-6376, 02/2016, Volume 71, Issue 2, pp. 107 - 109
SILDENAFIL | TADALAFIL | RESPIRATORY SYSTEM | BOSENTAN | Treatment Outcome | Hypertension, Pulmonary - drug therapy | Clinical Trials as Topic - methods | Antihypertensive Agents - therapeutic use | Drug Therapy, Combination | Humans | Tadalafil | Care and treatment | Usage | Clinical trials | Dosage and administration | Pulmonary hypertension | Ambrisentan
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
15. Full Text NonTuberculous Mycobacteria infection and lung transplantation in cystic fibrosis: A worldwide survey of clinical practice
by Tissot, Adrien and Thomas, Matthew F and Corris, Paul A and Brodlie, Malcolm
BMC Pulmonary Medicine, ISSN 1471-2466, 05/2018, Volume 18, Issue 1, pp. 86 - 5
In people with cystic fibrosis infection with NonTuberculous Mycobacteria is of increasing prevalence. Mycobacterium abscessus complex is of particular concern... 
Mycobacterium avium | Cystic fibrosis | Mycobacterium abscessus | Lung transplantation | Nontuberculous mycobacteria | Lung Transplantation | Mycobacterium avium Complex - isolation & purification | Cystic Fibrosis - microbiology | Internationality | Humans | Mycobacterium Infections, Nontuberculous - therapy | Surveys and Questionnaires | Cystic Fibrosis - complications | Mycobacterium Infections, Nontuberculous - epidemiology | Mycobacterium Infections, Nontuberculous - diagnosis | Mycobacterium abscessus - isolation & purification | Contraindications | Surveys | Complications and side effects | Care and treatment | Usage | Lungs | Buruli ulcer | Analysis | Outcome and process assessment (Health Care) | Transplantation | Risk factors
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
16. Full Text Effects of drug abuse, smoking and alcohol on donor hearts and lungs
by MacGowan, Guy A and Dark, John H and Corris, Paul A and Nair, Arun R
Transplant International, ISSN 0934-0874, 10/2019, Volume 32, Issue 10, pp. 1019 - 1027
Summary Potential heart and lung donors with a history of illicit drugs and/or smoking and alcohol are frequently offered, though there is no clear guidance on... 
drugs | donors | heart and lung transplantation | Developed countries | Drugs | Heart | Drug abuse | Transplants & implants | Narcotics | Syngeneic grafts | Heart transplantation | Lung transplantation | Organs | Alcohol | Transplantation | Drug screening | Immunosuppressive agents | Literature reviews | Cannabis | Lungs | Opioids | Alcoholic beverages | Cocaine | Smoking
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
17. Full Text Long-term (5 year) safety of bronchial thermoplasty: Asthma Intervention Research (AIR) trial
by Thomson, Neil C and Rubin, Adalberto S and Niven, Robert M and Corris, Paul A and Siersted, Hans C and Olivenstein, Ronald and Pavord, Ian D and McCormack, David and Laviolette, Michel and Shargill, Narinder S and Cox, Gerard and AIR Trial Study Grp and AIR Trial Study Group and the AIR Trial Study Group
BMC Pulmonary Medicine, ISSN 1471-2466, 02/2011, Volume 11, Issue 1, pp. 8 - 8
Background: Bronchial thermoplasty (BT) is a bronchoscopic procedure that improves asthma control by reducing excess airway smooth muscle. Treated patients... 
RESPIRATORY SYSTEM | Bronchoscopy - adverse effects | Severity of Illness Index | Spirometry | Asthma - physiopathology | Follow-Up Studies | Forced Expiratory Volume - physiology | Humans | Middle Aged | Bronchoscopy - methods | Male | Treatment Outcome | Lung - physiopathology | Adrenal Cortex Hormones - therapeutic use | Asthma - drug therapy | Vital Capacity - physiology | Muscle, Smooth - physiopathology | Adrenergic beta-2 Receptor Agonists - therapeutic use | Asthma - surgery | Adult | Female | Drug Therapy, Combination | Lung - surgery | Muscle, Smooth - surgery | Longitudinal Studies
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights